Purchase Order 75N98026P00617
Award Date 5/28/26
Potential Completion Date 5/27/27
Potential Value $34K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $94,156.42 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Life Technologies Corporation, a division of Thermo Fisher Scientific. The award is for the provision of an EVOS 7000 imaging system, incubator, and related accessories, with a performance period ending on December 8, 2022. The original solicitation was a brand name-restricted request for quotes,...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract has a ceiling value of $82,659.86 and an ultimate completion date of August 31, 2020. Life Technologies Corporation, doing business as Thermo Fisher Scientific, is providing a range of products and services to support biomedical research, applied markets, and forensic...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $18,232.42 firm fixed-price purchase order by the NIH Clinical Center on September 3, 2025, for the delivery of laboratory equipment including an E-Gel Power Snap Plus Electrophoresis System, Qubit 4 Fluorometer, and Veritipro Thermal instrument. The contract carries an ultimate completion date of October 3, 2025, and the place of performance is Carlsbad, California. No set-aside designation was applied to...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $476,157.04 firm fixed-price purchase order by the National Institute on Drug Abuse on September 25, 2020, for a flow cytometry system. The contract, which carries no set-aside designation, fulfills a solicitation issued by the National Institutes of Health National Institute on Neurological Disorders and Stroke. The equipment specified includes a 12-channel imaging cytometer equipped with 7 excitation...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) to Life Technologies Corporation (doing business as Thermo Fisher Scientific) for the provision of laboratory equipment, reagents, assays, and associated repair services to support biomedical research, medical readiness, and forensic analysis initiatives across multiple federal agencies. The $3,032.40 contract has an ultimate completion date of August 15, 2013 and does not utilize a set-aside designation....
- Life Technologies Corporation, operating as Thermo Fisher Scientific, was awarded a firm fixed-price purchase order valued at $10,924.97 by the Defense Health Agency's Bureau of Medicine and Surgery on April 23, 2025. The contract, which builds upon previous purchase order N3239824P0311, carries an ultimate completion date of April 23, 2026 and will be performed at the Silver Spring, Maryland location. No set-aside designation was used for this award, reflecting the contractor's competitive...
- This $12,282.76 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation (a division of Thermo Fisher Scientific) on July 26, 2024. The order is for a service agreement for a PCR system and a QuantStudio 5.0 instrument, to be performed at Life Technologies' facility in Carlsbad, CA. This contract does not have a set-aside designation...
- This $85,000.00 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Life Technologies Corporation (a division of Thermo Fisher Scientific) on January 25, 2017. The contract, which does not have a set-aside designation, is for the delivery of specialized biotechnology products and services to support NIAID's biomedical research and healthcare initiatives. As a...
- This is a federal contract award with a ceiling value of $20,464.68, awarded by the Office of Logistics and Acquisition Operations (a civilian agency) to Life Technologies Corporation, doing business as Thermo Fisher Scientific. The contract is a Blanket Purchase Agreement (BPA) call order, with a Firm Fixed Price pricing type, and an ultimate completion date of April 30, 2026. The contract does not have a set-aside designation. The contract provides for the delivery of specialized scientific...
- This $14,114.96 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract provides 1 year of service and support for a QuantStudio instrument, which is likely a DNA sequencing platform used to support NIAID's research initiatives in areas such as infectious disease, immunology,...
The National Institute of Biomedical Imaging and Bioengineering awarded a purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on May 28, 2026, with a ceiling value of $34,319.97 and performance due by May 27, 2027. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside applied. No specific statement of work or requirement description appears in the source; the contracting documentation references CX7PRO LZR equipment and AB PROTECTION designation, suggesting procurement of specialized laboratory instrumentation or consumables consistent with the vendor's biotechnology product portfolio.
Generated 5/30/26, 10:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.3k | 5/28/26 |